Annual EBIT:
-$451.22M-$90.30M(-25.02%)Summary
- As of today, MDGL annual earnings before interest & taxes is -$451.22 million, with the most recent change of -$90.30 million (-25.02%) on December 31, 2024.
- During the last 3 years, MDGL annual EBIT has fallen by -$209.38 million (-86.57%).
- MDGL annual EBIT is now -660.24% below its all-time high of $80.54 million, reached on December 31, 2009.
Performance
MDGL EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$113.97M-$66.77M(-141.46%)Summary
- As of today, MDGL quarterly earnings before interest & taxes is -$113.97 million, with the most recent change of -$66.77 million (-141.46%) on September 30, 2025.
- Over the past year, MDGL quarterly EBIT has increased by +$2.33 million (+2.00%).
- MDGL quarterly EBIT is now -196.45% below its all-time high of $118.17 million, reached on September 30, 2009.
Performance
MDGL Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$307.49M+$2.33M(+0.75%)Summary
- As of today, MDGL TTM earnings before interest & taxes is -$307.49 million, with the most recent change of +$2.33 million (+0.75%) on September 30, 2025.
- Over the past year, MDGL TTM EBIT has increased by +$240.57 million (+43.90%).
- MDGL TTM EBIT is now -428.93% below its all-time high of $93.48 million, reached on March 31, 2010.
Performance
MDGL TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
MDGL EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -25.0% | +2.0% | +43.9% |
| 3Y3 Years | -86.6% | -41.7% | -12.7% |
| 5Y5 Years | -375.1% | -93.9% | -73.7% |
MDGL EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -86.6% | at low | -141.5% | +29.9% | -12.7% | +43.9% |
| 5Y | 5-Year | -375.1% | at low | -141.5% | +29.9% | -73.7% | +43.9% |
| All-Time | All-Time | -660.2% | at low | -196.4% | +29.9% | -428.9% | +43.9% |
MDGL EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$113.97M(-141.5%) | -$307.49M(+0.8%) |
| Jun 2025 | - | -$47.20M(+40.5%) | -$309.81M(+27.1%) |
| Mar 2025 | - | -$79.31M(-18.4%) | -$425.15M(+14.6%) |
| Dec 2024 | -$451.22M(-25.0%) | -$67.00M(+42.4%) | -$497.88M(+9.2%) |
| Sep 2024 | - | -$116.30M(+28.4%) | -$548.05M(-3.4%) |
| Jun 2024 | - | -$162.54M(-6.9%) | -$530.28M(-16.8%) |
| Mar 2024 | - | -$152.04M(-29.8%) | -$454.20M(-19.4%) |
| Dec 2023 | -$360.92M(-23.9%) | -$117.18M(-18.9%) | -$380.50M(-9.1%) |
| Sep 2023 | - | -$98.53M(-14.0%) | -$348.62M(-5.5%) |
| Jun 2023 | - | -$86.45M(-10.4%) | -$330.50M(-5.1%) |
| Mar 2023 | - | -$78.34M(+8.2%) | -$314.32M(-7.1%) |
| Dec 2022 | -$291.39M(-20.5%) | -$85.30M(-6.1%) | -$293.57M(-7.6%) |
| Sep 2022 | - | -$80.41M(-14.4%) | -$272.87M(-6.7%) |
| Jun 2022 | - | -$70.27M(-22.0%) | -$255.62M(-3.5%) |
| Mar 2022 | - | -$57.59M(+10.9%) | -$247.09M(-1.9%) |
| Dec 2021 | -$241.85M(-17.0%) | -$64.60M(-2.3%) | -$242.48M(-2.1%) |
| Sep 2021 | - | -$63.16M(-2.3%) | -$237.44M(-1.9%) |
| Jun 2021 | - | -$61.74M(-16.5%) | -$233.06M(-5.2%) |
| Mar 2021 | - | -$52.98M(+11.0%) | -$221.65M(-7.2%) |
| Dec 2020 | -$206.67M(-117.6%) | -$59.55M(-1.3%) | -$206.67M(-16.7%) |
| Sep 2020 | - | -$58.79M(-16.8%) | -$177.07M(-24.3%) |
| Jun 2020 | - | -$50.33M(-32.4%) | -$142.48M(-24.0%) |
| Mar 2020 | - | -$38.01M(-26.9%) | -$114.86M(-20.9%) |
| Dec 2019 | -$94.97M(-133.4%) | -$29.95M(-23.8%) | -$94.97M(-19.5%) |
| Sep 2019 | - | -$24.20M(-6.6%) | -$79.47M(-19.3%) |
| Jun 2019 | - | -$22.70M(-25.3%) | -$66.61M(-28.8%) |
| Mar 2019 | - | -$18.12M(-25.4%) | -$51.73M(-27.2%) |
| Dec 2018 | -$40.68M(-26.9%) | -$14.45M(-27.5%) | -$40.68M(-15.8%) |
| Sep 2018 | - | -$11.33M(-44.8%) | -$35.14M(-8.3%) |
| Jun 2018 | - | -$7.83M(-10.7%) | -$32.44M(+1.9%) |
| Mar 2018 | - | -$7.07M(+20.7%) | -$33.06M(-3.1%) |
| Dec 2017 | -$32.06M(-27.4%) | -$8.91M(-3.2%) | -$32.06M(-4.0%) |
| Sep 2017 | - | -$8.64M(-2.3%) | -$30.83M(+14.7%) |
| Jun 2017 | - | -$8.44M(-38.9%) | -$36.16M(-19.1%) |
| Mar 2017 | - | -$6.08M(+20.9%) | -$30.36M(-21.3%) |
| Dec 2016 | -$25.18M(-678.7%) | -$7.68M(+45.0%) | -$25.02M(-36.3%) |
| Sep 2016 | - | -$13.96M(-429.0%) | -$18.35M(-249.4%) |
| Jun 2016 | - | -$2.64M(-257.6%) | -$5.25M(+76.2%) |
| Mar 2016 | - | -$738.00K(+27.4%) | -$22.12M(+47.0%) |
| Dec 2015 | -$3.23M(+96.1%) | -$1.02M(-18.2%) | -$41.71M(+31.2%) |
| Sep 2015 | - | -$860.00K(+95.6%) | -$60.59M(+23.5%) |
| Jun 2015 | - | -$19.50M(+4.1%) | -$79.18M(+2.7%) |
| Mar 2015 | - | -$20.33M(-2.2%) | -$81.38M(+3.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2014 | -$83.95M(+4.1%) | -$19.89M(-2.3%) | -$83.95M(+4.1%) |
| Sep 2014 | - | -$19.45M(+10.4%) | -$87.50M(+2.6%) |
| Jun 2014 | - | -$21.70M(+5.3%) | -$89.85M(+0.4%) |
| Mar 2014 | - | -$22.91M(+2.3%) | -$90.21M(-3.0%) |
| Dec 2013 | -$87.56M(-43.7%) | -$23.44M(-7.6%) | -$87.56M(-7.0%) |
| Sep 2013 | - | -$21.79M(+1.2%) | -$81.82M(-9.7%) |
| Jun 2013 | - | -$22.06M(-8.9%) | -$74.56M(-11.4%) |
| Mar 2013 | - | -$20.26M(-14.4%) | -$66.93M(-9.0%) |
| Dec 2012 | -$60.94M(-34.1%) | -$17.70M(-21.8%) | -$61.39M(-13.8%) |
| Sep 2012 | - | -$14.54M(-0.7%) | -$53.92M(-4.5%) |
| Jun 2012 | - | -$14.43M(+1.9%) | -$51.60M(-4.9%) |
| Mar 2012 | - | -$14.71M(-43.7%) | -$49.18M(-8.2%) |
| Dec 2011 | -$45.43M(-23.1%) | -$10.24M(+16.2%) | -$45.43M(-4.3%) |
| Sep 2011 | - | -$12.22M(-1.7%) | -$43.56M(-4.8%) |
| Jun 2011 | - | -$12.01M(-9.5%) | -$41.57M(-7.7%) |
| Mar 2011 | - | -$10.97M(-31.1%) | -$38.61M(-4.6%) |
| Dec 2010 | -$36.90M(-145.8%) | -$8.37M(+18.2%) | -$36.90M(-3.9%) |
| Sep 2010 | - | -$10.23M(-13.1%) | -$35.51M(-138.2%) |
| Jun 2010 | - | -$9.04M(+2.3%) | $92.89M(-0.6%) |
| Mar 2010 | - | -$9.26M(-32.6%) | $93.48M(+14.3%) |
| Dec 2009 | $80.54M(+185.9%) | -$6.98M(-105.9%) | $81.78M(+30.0%) |
| Sep 2009 | - | $118.17M(+1498.0%) | $62.89M(+176.9%) |
| Jun 2009 | - | -$8.45M(+59.7%) | -$81.73M(+15.1%) |
| Mar 2009 | - | -$20.96M(+19.0%) | -$96.23M(-2.7%) |
| Dec 2008 | -$93.71M(-41.5%) | -$25.86M(+2.2%) | -$93.71M(-11.3%) |
| Sep 2008 | - | -$26.45M(-15.3%) | -$84.19M(-15.1%) |
| Jun 2008 | - | -$22.95M(-24.4%) | -$73.13M(-8.1%) |
| Mar 2008 | - | -$18.45M(-12.9%) | -$67.65M(-2.2%) |
| Dec 2007 | -$66.22M(-11.9%) | -$16.34M(-6.2%) | -$66.22M(-5.3%) |
| Sep 2007 | - | -$15.39M(+11.9%) | -$62.88M(-1.3%) |
| Jun 2007 | - | -$17.47M(-2.7%) | -$62.06M(-4.2%) |
| Mar 2007 | - | -$17.01M(-30.8%) | -$59.58M(-0.7%) |
| Dec 2006 | -$59.15M(+16.9%) | -$13.01M(+10.8%) | -$59.15M(-28.2%) |
| Sep 2006 | - | -$14.58M(+2.7%) | -$46.15M(-46.2%) |
| Jun 2006 | - | -$14.98M(+9.7%) | -$31.57M(-90.3%) |
| Mar 2006 | - | -$16.59M(+10.3%) | -$16.59M(+10.3%) |
| Dec 2005 | -$71.18M(-57.0%) | - | - |
| Mar 2005 | - | -$18.50M(-239.3%) | -$18.50M(-239.3%) |
| Dec 2004 | -$45.35M(-60.3%) | - | - |
| Mar 2004 | - | -$5.45M | -$5.45M |
| Dec 2003 | -$28.29M(-288.0%) | - | - |
| Dec 2002 | -$7.29M(-1718.5%) | - | - |
| Dec 2001 | -$401.00K | - | - |
FAQ
- What is Madrigal Pharmaceuticals, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Madrigal Pharmaceuticals, Inc.?
- What is Madrigal Pharmaceuticals, Inc. annual EBIT year-on-year change?
- What is Madrigal Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Madrigal Pharmaceuticals, Inc.?
- What is Madrigal Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
- What is Madrigal Pharmaceuticals, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Madrigal Pharmaceuticals, Inc.?
- What is Madrigal Pharmaceuticals, Inc. TTM EBIT year-on-year change?
What is Madrigal Pharmaceuticals, Inc. annual earnings before interest & taxes?
The current annual EBIT of MDGL is -$451.22M
What is the all-time high annual EBIT for Madrigal Pharmaceuticals, Inc.?
Madrigal Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is $80.54M
What is Madrigal Pharmaceuticals, Inc. annual EBIT year-on-year change?
Over the past year, MDGL annual earnings before interest & taxes has changed by -$90.30M (-25.02%)
What is Madrigal Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of MDGL is -$113.97M
What is the all-time high quarterly EBIT for Madrigal Pharmaceuticals, Inc.?
Madrigal Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is $118.17M
What is Madrigal Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
Over the past year, MDGL quarterly earnings before interest & taxes has changed by +$2.33M (+2.00%)
What is Madrigal Pharmaceuticals, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of MDGL is -$307.49M
What is the all-time high TTM EBIT for Madrigal Pharmaceuticals, Inc.?
Madrigal Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is $93.48M
What is Madrigal Pharmaceuticals, Inc. TTM EBIT year-on-year change?
Over the past year, MDGL TTM earnings before interest & taxes has changed by +$240.57M (+43.90%)